{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:26:42Z","timestamp":1735583202702},"reference-count":12,"publisher":"Codon Publications","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.aller.2013.09.010","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T11:00:34Z","timestamp":1389178834000},"page":"127-130","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs"],"prefix":"10.15586","volume":"43","author":[{"given":"Paola Lucia","family":"Minciullo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2013.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/annonc\/mdn356","article-title":"Disambiguating the bisphosphonates","volume":"19","author":"Van den Wyngaert","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.aller.2013.09.010_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/107327480200900605","article-title":"The use of bisphosphonates in patients with breast cancer","volume":"9","author":"Van Poznak","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.aller.2013.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE). Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.aller.2013.09.010_bib0020","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.aller.2013.09.010_bib0025","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1080\/10428190701509806","article-title":"Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1","volume":"48","author":"Alonci","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.aller.2013.09.010_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000313787","article-title":"Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws","volume":"124","author":"Allegra","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.aller.2013.09.010_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cyto.2008.05.010","article-title":"Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration","volume":"43","author":"Oteri","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.aller.2013.09.010_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1759720X10387202","article-title":"Cutaneousside effects of antiosteoporosis treatments","volume":"3","author":"Musette","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.aller.2013.09.010_bib0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0091-6749(98)70291-X","article-title":"Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management","volume":"102","author":"Phillips","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2013.09.010_bib0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00301637","article-title":"Long-lasting dermatological lesions after tiludronate therapy","volume":"50","author":"Roux","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.aller.2013.09.010_bib0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/rheumatology\/34.8.798","article-title":"Toxic epidermal necrolysis, pancytopenia and adult respiratory syndrome","volume":"34","author":"Coakley","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.aller.2013.09.010_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000323227","article-title":"Safety and reliability of the drug tolerance test: our experience in 739 patients","volume":"87","author":"Gangemi","year":"2011","journal-title":"Pharmacology"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054613002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054613002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:49:50Z","timestamp":1609454990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054613002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0301054613002838"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2013.09.010","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 SEICAP. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}